Daily Anesthesiology Research Analysis
Three studies in anesthesiology stand out today: a randomized trial shows driving pressure–guided dynamic PEEP titration reduces atelectasis and improves oxygenation in pediatric laparoscopy; a cardiac surgery RCT demonstrates deep parasternal intercostal plane block yields superior opioid-sparing analgesia after CABG; and a meta-analysis confirms even 2–4 weeks of preoperative smoking cessation lowers postoperative complications, with greater benefit at longer intervals.
Summary
Three studies in anesthesiology stand out today: a randomized trial shows driving pressure–guided dynamic PEEP titration reduces atelectasis and improves oxygenation in pediatric laparoscopy; a cardiac surgery RCT demonstrates deep parasternal intercostal plane block yields superior opioid-sparing analgesia after CABG; and a meta-analysis confirms even 2–4 weeks of preoperative smoking cessation lowers postoperative complications, with greater benefit at longer intervals.
Research Themes
- Personalized intraoperative ventilation
- Regional anesthesia optimization in cardiac surgery
- Preoperative smoking cessation and postoperative outcomes
Selected Articles
1. Driving pressure-guided dynamic PEEP titration reduces atelectasis and improves oxygenation in pediatric laparoscopy: a randomized trial on personalized ventilation strategies.
In pediatric laparoscopy, driving pressure–guided dynamic PEEP titration at multiple intraoperative time points reduced lung ultrasound abnormalities and atelectasis, improved oxygenation and respiratory mechanics, and maintained hemodynamic stability compared with a single titration after intubation. The strategy also shortened extubation time according to study notes.
Impact: This RCT demonstrates a practical, individualized ventilation protocol that reduces atelectasis and improves oxygenation in a high-risk pediatric population, supporting a shift from static to dynamic PEEP strategies.
Clinical Implications: Adopt driving pressure–guided dynamic PEEP titration at key intraoperative milestones (post-intubation, pre- and post-pneumoperitoneum) with recruitment maneuvers to minimize atelectasis and optimize oxygenation in pediatric laparoscopy.
Key Findings
- Dynamic, driving pressure–guided PEEP titration reduced intraoperative lung ultrasound scores and atelectasis at end of surgery and extubation versus single titration after intubation.
- Oxygenation and respiratory mechanics (lower driving pressure, improved compliance) improved without hemodynamic instability.
- Study notes indicate shorter postoperative extubation time with dynamic PEEP titration.
Methodological Strengths
- Randomized design with predefined intraoperative titration time points
- Use of lung ultrasound and respiratory mechanics as objective endpoints; trial registration available
Limitations
- Retrospective trial registration and blinding not described
- Single-center details and total sample size not specified in abstract
Future Directions: Conduct multicenter, blinded RCTs with predefined PPC endpoints to validate generalizability, assess long-term outcomes, and integrate automated driving pressure–guided algorithms.
BACKGROUND: Pediatric laparoscopic surgery often induces atelectasis due to pneumoperitoneum, postural changes, and immature respiratory physiology, increasing postoperative pulmonary complications (PPCs). Fixed PEEP may fail to address perioperative variability. This study evaluated whether dynamic PEEP adjustment reduces atelectasis and improves oxygenation. METHODS: Children at moderate or high risk of PPCs undergoing elective laparoscopic surgery were randomized into two groups. Group A had driving pressure-guided individualized PEEP titration at three specified time points: after intubation, before pneumoperitoneum initiation, and after pneumoperitoneum completion. Group B had individualized PEEP titration only after intubation, with this PEEP maintained until the end of ventilation. Both groups received alveolar recruitment maneuvers (ARMs). Observations were conducted at 5 min after tracheal intubation (T1), 20 min post-pneumoperitoneum (T2), 60 min post-pneumoperitoneum (T3), at the end of surgery (T4), and at extubation (T5). The primary outcome were intraoperative lung ultrasound score. Secondary outcomes included incidence of atelectasis, oxygenation index, peak airway pressure, plateau pressure, PEEP, driving pressure, dynamic lung compliance, mean arterial pressure, and heart rate. RESULTS: At T4 and T5, Group A showed significantly lower subpleural consolidation scores, total lung ultrasound scores, and atelectasis rates versus Group B ( CONCLUSION: Driving pressure-guided dynamic PEEP titration reduces postoperative lung ultrasound abnormalities and atelectasis while improving oxygenation and respiratory mechanics in pediatric laparoscopy, without compromising hemodynamic stability. This strategy supports personalized PEEP optimization. TRIAL REGISTRATION: This trial was registered on Clinical Trials.gov (Registration No. ChiCTR2300070193, Registration date: 2023-04-04). The trial was retrospectively registered as enrollment began prior to registration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-025-03274-w. UNLABELLED: • Compared to static PEEP strategies, driving pressure-guided dynamic PEEP titration during pediatric laparoscopic surgery significantly reduces intraoperative atelectasis, improves oxygenation, and shortens postoperative extubation time. • Driving pressure-guided dynamic PEEP titration optimizes respiratory mechanics under pneumoperitoneum, offering a feasible non-invasive approach to personalized lung protection in children. • The driving pressure-guided dynamic PEEP titration demonstrated robust safety by maintaining hemodynamic stability while enhancing pulmonary compliance and minimizing ventilator-induced lung injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-025-03274-w.
2. A Single-blind, Randomized Controlled Trial Comparing Postoperative Analgesic Effects of Superficial and Deep Parasternal Intercostals Blocks in Patients Undergoing Coronary Artery Bypass Grafting Surgery.
In patients undergoing CABG via median sternotomy, deep parasternal intercostal plane block performed under direct vision significantly reduced 24-hour tramadol consumption versus superficial block and control, with lower pain scores and no block-related complications. Superficial block also improved analgesia compared with control but was less effective than deep block.
Impact: Provides randomized comparative evidence to optimize sternal analgesia after CABG, favoring a technique (DPIPB) with clear opioid-sparing benefits and feasibility.
Clinical Implications: Incorporate DPIPB into multimodal analgesia pathways for CABG to reduce opioid requirements and improve dynamic pain control; consider workflow integration with surgeon-performed direct vision technique.
Key Findings
- DPIPB reduced 24-hour tramadol use (95 ± 44 mg) versus SPIPB (141 ± 58 mg) and control (176 ± 61 mg), p < 0.001.
- Both DPIPB and SPIPB lowered pain scores at all time points compared with control; DPIPB had the most pronounced effect.
- No block-related complications occurred; DPIPB markedly reduced the odds of high-dose tramadol use (OR 0.18 vs control).
Methodological Strengths
- Prospective randomized single-blind three-arm design with clinically meaningful primary endpoint (24-hour opioid use)
- Direct comparison of ultrasound-guided superficial versus surgeon-performed deep plane block; no block-related adverse events
Limitations
- Single-center study with modest sample size (n=75) may limit generalizability
- Blinding limited to single-blind; potential performance bias
Future Directions: Multicenter trials to confirm superiority of DPIPB across diverse cardiac procedures, evaluate functional recovery, pulmonary outcomes, and cost-effectiveness.
OBJECTIVE: To compare the analgesic efficacy of anesthesiologist-performed ultrasound-guided superficial parasternal intercostal plane block (SPIPB) and surgeon-performed deep parasternal intercostal plane block (DPIPB) in patients undergoing coronary artery bypass grafting (CABG) via median sternotomy. DESIGN: A prospective, randomized, single-blind clinical trial. SETTING: A single, tertiary care university hospital. PARTICIPANTS: Seventy-five participants (aged 45-80 years, ASA III-IV) scheduled for elective isolated CABG surgery. INTERVENTIONS: Participants were randomly assigned to the SPIPB, DPIPB, or control groups. Regional blocks were performed either under ultrasound guidance after sternal closure and sterilization of the surgical site (SPIPB) or intraoperatively under direct vision (DPIPB). Postoperative pain was managed with multimodal analgesia protocols. MEASUREMENTS AND MAIN RESULTS: Outcomes included pain scores and tramadol administration at the 1st, 4th, 12th, and 24th postoperative hours, as well as after extubation. The cumulative 24-hour tramadol administration (primary outcome) was significantly lower in the DPIPB group (95 ± 44 mg) compared with the SPIPB (141 ± 58 mg) and control groups (176 ± 61 mg) (p < 0.001). Compared with the control group, the DPIPB group had a significantly reduced likelihood of requiring high-dose tramadol (odds ratio [OR]: 0.18, 95% confidence interval [CI]: 0.06-0.56, p = 0.003). The SPIPB group showed an intermediate effect compared with control (OR: 0.52, 95% CI: 0.23-1.18, p = 0.095). When directly compared, DPIPB was associated with significantly lower tramadol use than SPIPB (OR: 0.34, 95% CI: 0.16-0.72, p < 0.001). Pain scores at all time points were significantly lower in both block groups compared with control (p < 0.05), with DPIPB showing the most pronounced effect. No block-related complications were observed. CONCLUSIONS: Both parasternal intercostal blocks improved postoperative analgesia compared with standard care. The SPIPB was performed under ultrasound guidance, whereas the DPIPB was applied under direct vision by the surgeon. The DPIPB demonstrated superior opioid-sparing effects and improved dynamic pain control. These findings support the use of parasternal fascial plane blocks, whether performed under ultrasound guidance or direct vision, as effective components of multimodal analgesia in cardiac surgery.
3. Impact of short duration smoking cessation on post-operative complications: A systematic review and meta-analysis.
Across 55 studies, preoperative smoking cessation of at least 2–4 weeks reduced postoperative pulmonary complications by 27–29% and, at ≥4 weeks, decreased wound and composite complications and mortality. Benefits increased with longer cessation (≥8 weeks), while effects on surgical site infection and bleeding were not significant.
Impact: Delivers dose–response evidence that even short preoperative cessation windows confer meaningful risk reduction, supporting scalable anesthesia-led preoperative optimization programs.
Clinical Implications: Implement systematic preoperative smoking cessation interventions at the pre-assessment visit, offering pharmacotherapy and counseling, emphasizing that 2–4 weeks of cessation already reduces risk, with greater benefits up to ≥8 weeks.
Key Findings
- Compared with active smokers, pulmonary complications decreased by 27% at ≥2 weeks (RR 0.73), 29% at ≥4 weeks (RR 0.71), and 37% at ≥8 weeks (RR 0.63) of preoperative cessation.
- At ≥4 weeks of cessation, wound complications fell by 33% (RR 0.67), composite complications by 31% (RR 0.69), and mortality by 14% (RR 0.86).
- Short-term cessation showed no significant impact on surgical site infection or bleeding.
Methodological Strengths
- Comprehensive systematic review and meta-analysis synthesizing 55 studies with multiple clinically relevant endpoints
- Demonstrates dose–response relationship between cessation duration and risk reduction
Limitations
- Heterogeneity across included studies and potential residual confounding in observational data
- Cessation verification and adherence vary; some outcomes (SSI, bleeding) showed no significant effect
Future Directions: Prospective, standardized cessation programs with biochemical verification to refine effect estimates by surgery type and risk strata; evaluate cost-effectiveness and implementation strategies.
BACKGROUND: Use of tobacco poses significant health risks, particularly in surgical patients, where smoking is a well-established risk factor for postoperative complications. Patients are often seen in the pre-assessment clinic 2-4 weeks prior to surgery, presenting a window of opportunity to intervene. The objective of our systematic review and meta-analysis is to explore the impact of short-term smoking cessation on postoperative outcomes, focusing on the critical 2-4-week period preceding surgery. DESIGN: Systematic review and meta-analysis. SETTING: MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. PATIENTS: Adults undergoing surgical procedures with a defined smoking cessation pre-operative smoking cessation interval. MEASUREMENT: Post-operative complications including pulmonary complications, surgical site infection, wound complication, bleeding, mortality, and composite complications. RESULTS: Fifty-five studies were included in the systematic review and meta-analysis. Pulmonary complications were more prevalent in former smokers compared to non-smokers, even after cessation. Progressively longer smoking cessation periods showed improved outcomes. Compared to active smokers, preoperative cessation reduced pulmonary complications by 27 % at ≥2 weeks (RR 0.73, 95 % CI 0.60-0.89), 29 % at ≥4 weeks (RR 0.71, 95 % CI 0.61-0.82), and 37 % at ≥8 weeks (RR 0.63, 95 % CI 0.41-0.95). With ≥4 weeks of cessation, there was a 33 % lower risk of wound complications (RR 0.67, 95 % CI 0.47-0.94), 31 % lower risk of composite complications (RR 0.69, 95 %CI 0.63-0.76), and 14 % lower risk of mortality (RR 0.86, 95 % CI 0.77-0.97). Short term cessation did not seem to have a significant impact on surgical site infections or bleeding. CONCLUSIONS: Short term cessation of at least 2-4 weeks demonstrates benefits in reducing post-operative complications.